Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFß, in Advanced Solid Tumors.
Clin Cancer Res
; 24(6): 1287-1295, 2018 03 15.
Article
in En
| MEDLINE
| ID: mdl-29298798
Full text:
1
Database:
MEDLINE
Main subject:
Transforming Growth Factor beta
/
Antibodies, Bispecific
/
B7-H1 Antigen
/
Antineoplastic Agents, Immunological
/
Neoplasms
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2018
Type:
Article